News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Oil futures rose after Iran said it halted vessels in the Strait of Hormuz, raising energy supply risk.
  • Amazon reported a blowout quarter with AWS revenue up 36.8% and raised multi-year capex guidance.
  • Multiple autonomous AI agents breached corporate systems in separate incidents, prompting cybersecurity concerns for enterprises.
  • European equity markets traded mixed with modest gains in Helsinki, Stockholm, Paris and Madrid but losses in UK, Netherlands and Portugal.
  • Linde and Reddit beat Q2 estimates but stocks fell as margin compression and licensing uncertainty spooked investors respectively.
  • U.S. releases a 10-year Colorado River plan limiting Lake Powell releases and signaling likely Lower Basin shortages.

Latest Articles

TTEC Digital Signs Strategic Collaboration Agreement with AWS to Accelerate Amazon Connect Adoption

TTEC Digital Signs Strategic Collaboration Agreement with AWS to Accelerate Amazon Connect Adoption

TTEC Digital has entered a strategic collaboration agreement with Amazon Web Services to enhance adoption of Amazon Connect by integrating AI-powered customer experience solutions, simplifying contact center modernization. This partnership aims to deliver intelligent self-service, agent assistance, and real-time data capabilities to organizations, …

electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia

electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia

electroCore announced new clinical findings published in JAMA Network Open demonstrating that adding the Quell electrical nerve stimulation device to outpatient physical therapy significantly reduces movement-evoked pain and fatigue in fibromyalgia patients, with benefits observed within 30 days and sustained up to six months.

ZUSDURI Median Duration of Response Still Not Reached with 64.5% 36-month Duration of Response in the Pivotal ENVISION Trial

ZUSDURI Median Duration of Response Still Not Reached with 64.5% 36-month Duration of Response in the Pivotal ENVISION Trial

UroGen Pharma Ltd. announced positive 36-month duration of response data from its Phase 3 ENVISION trial of ZUSDURI (mitomycin) for recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC). The Kaplan-Meier analysis showed 64.5% of patients achieving complete response at three months remained event-free at three years,…

INmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech Sector Navigates Strategic Inflection Point

INmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech Sector Navigates Strategic Inflection Point

INmune Bio announced it as a founding member of the American Biotech Innovation Alliance (ABIA), a coalition of biotechnology companies working to develop a national strategy to maintain and extend U.S. leadership in biotech innovation. The alliance will address key industry challenges such as manufacturing capacity, early research investment, regu…

Calidi Biotherapeutics Confirms Featured Speaker Presentation Tomorrow at the ASGCT Conference in Boston

Calidi Biotherapeutics Confirms Featured Speaker Presentation Tomorrow at the ASGCT Conference in Boston

Calidi Biotherapeutics announced that Dr. Antonio F. Santidrian, CSO, will present new data at the ASGCT conference highlighting the company's proprietary RedTail virotherapy platform and lead candidate CLD-401, which targets tumors via systemic delivery and exhibits immune activating properties. The company plans to file an IND for CLD-401 by the …

LiqTech International Announces First Quarter 2026 Financial Results

LiqTech International Announces First Quarter 2026 Financial Results

LiqTech International announced its Q1 2026 financial results showing a slight decline in revenue to $4.1 million compared to the prior year, and a net loss widening to $2.7 million. The company highlighted growth in commercial pool and marine water treatment markets along with a positive outlook expecting 39% to 64% revenue growth for full-year 20…

Moleculin Announces Imminent MIRACLE Trial Unblinding as Blinded Data Continue to Significantly Outperform Historical Benchmarks

Moleculin Announces Imminent MIRACLE Trial Unblinding as Blinded Data Continue to Significantly Outperform Historical Benchmarks

Moleculin Biotech announced that the MIRACLE trial evaluating Annamycin plus cytarabine in relapsed/refractory acute myeloid leukemia (AML) is on track for first interim unblinding of data by June 30, 2026. Preliminary blinded data from 45 patients show a complete remission rate (~30%) approximately double historical rates for cytarabine alone. Rec…

Swarmer Reports First Quarter Financial Results

Swarmer Reports First Quarter Financial Results

Swarmer, Inc, a drone autonomy software company, reported its first quarter 2026 financial results following its successful Nasdaq IPO. The company raised $17.3 million and announced key contract wins and expansion into Japan. Despite these positive developments, revenue declined significantly due to the conclusion of a major customer engagement, w…

Diginex Appoints Archana Kotecha as Chief Impact Officer to Advance Human Rights and Scale Supply Chain Solutions in a $9.6B Market

Diginex Appoints Archana Kotecha as Chief Impact Officer to Advance Human Rights and Scale Supply Chain Solutions in a $9.6B Market

Diginex Limited appoints Archana Kotecha, founder of The Remedy Project, as Chief Impact Officer to enhance its human rights and supply chain due diligence capabilities amid a rapidly growing $9.6 billion market. The move supports Diginex's strategy to scale sustainable regulatory compliance solutions using advanced technologies and expands its glo…

ARS Pharmaceuticals Strengthens Leadership Team with Appointment of Industry Veteran Donn Casale as President

ARS Pharmaceuticals Strengthens Leadership Team with Appointment of Industry Veteran Donn Casale as President

ARS Pharmaceuticals has announced the appointment of Donn Casale as its new President, effective June 1, 2026. Casale brings 25 years of biopharmaceutical commercial leadership experience, having previously scaled successful healthcare products. His role will focus on overseeing global commercial operations and driving growth, particularly advancin…

NOVAGOLD Releases 2025 Sustainability Report

NOVAGOLD Releases 2025 Sustainability Report

NOVAGOLD Resources Inc. released its 2025 Sustainability Report detailing its environmental, social, and governance (ESG) performance aligned with global standards such as TCFD and TNFD. The report emphasizes NOVAGOLD's responsible advancement of the Donlin Gold project, strong community engagement, and commitment to sustainable mining development …

Esperion Announces Two New Analyses Supporting Bempedoic Acid to Reduce LDL-C Levels to be Presented at the European Atherosclerosis Society (EAS) Congress 2026

Esperion Announces Two New Analyses Supporting Bempedoic Acid to Reduce LDL-C Levels to be Presented at the European Atherosclerosis Society (EAS) Congress 2026

Esperion Therapeutics announced the presentation of new analyses at the European Atherosclerosis Society Congress 2026. The data highlights the efficacy of bempedoic acid in lowering LDL cholesterol in children with heterozygous familial hypercholesterolemia as well as factors enhancing LDL-C reduction in adults. These findings support advancing be…

Gildan Announces the Publication of its 2025 Sustainability Report Highlighting Continued Progress Towards Key Social and Environmental Targets¹

Gildan Announces the Publication of its 2025 Sustainability Report Highlighting Continued Progress Towards Key Social and Environmental Targets¹

Gildan Activewear Inc. released its 22nd Sustainability Report showcasing continued achievements under its Next Generation Sustainability strategy. In 2025, the company met its sustainable cotton sourcing goals, reduced water intensity by approximately 25%, increased recycled fiber usage, and enhanced health and safety standards with ISO certificat…

Axon Shares Slip After Investor Highlights AI Potential at Sohn Conference

Axon Shares Slip After Investor Highlights AI Potential at Sohn Conference

Axon Enterprise shares edged lower after investor Rahul Kishore presented the company at the Sohn investment conference at Lincoln Center. Kishore, founder of Epicenter Capital and former Coatue executive, framed Axon's growth prospects around artificial intelligence. The presentation included an AI-generated introduction from an assistant named Ev…